Sovereign Metals #SVML – Sprott increases shareholding from 10.41% to 11.84%
Sovereign Metals Limited (ASX:SVM; AIM:SVML) (Sovereign or the Company) advises that it was today notified via the filing of a Form 604 with the Australian Securities Exchange (ASX) that Sprott Inc. and each of its controlled bodies (Sprott) provided a notice of change of interests of substantial holder (as defined by the Corporations Act 2001) […]
Power Metal Resources #POW – Ditau Project – Drilling and Geophysics Update
Power Metal Resources plc (LON:POW), the London listed exploration company seeking large-scale metal discoveries across its global project portfolio announces a drilling update in respect of the Ditau Camp Project (“Ditau”), located in southwestern Botswana. Ditau is considered prospective for carbonatite hosted rare-earth element (“REE”), base metal and possible precious metal mineralisation. Ditau is held within […]
Kavango Resources #KAV – Ditau drilling and AMT update
Botswana focussed metals exploration company Kavango Resources plc (LSE:KAV) has successfully completed hole DITDD005 on the “i1” target (“Target i1”) at the Ditau Camp Project (“Ditau”). The Company has now moved the drill rig to the “i8” target (“Target i8”), Hole DITDD006, following the completion of a Controlled Source Audio-Magnetotelluric (CSAMT) ground geophysical survey and […]
Tertiary Minerals #TYM – Resignation of Managing Director
Tertiary Minerals plc (LON: TYM), the AIM traded mineral exploration and development company, whose strategic focus is on energy transition metals, advises that it has received and accepted a letter of resignation from its Managing Director, Mr. Patrick Cullen, effective 20 June 2022. The Company will seek to recruit a replacement Managing Director, with Mr. […]
Sovereign Metals #SVML – ASX Trading Halt Pending Kasiya Announcement
Sovereign Metals Limited (ASX:SVM; AIM:SVML) (Sovereign or the Company) advises that today the Company requested an immediate voluntary trading halt in its shares on the Australian Securities Exchange (ASX), pending an announcement regarding an expanded scoping study at Kasiya. The Company has requested that the trading halt remain until the earlier of an announcement to […]
Open Orphan #ORPH – £7.2m RSV human challenge study contract
Open Orphan (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, announces that hVIVO, a subsidiary of Open Orphan, has signed a £7.2m contract with an existing top 5 global pharmaceutical company to test its orally administered antiviral product, […]
Alan Green covers Cobra Resources #COBR & Open Orphan #ORPH on this week’s Stockbox Research Talks
Alan Green covers Cobra Resources #COBR & Open Orphan #ORPH on this week’s Stockbox Research Talks
ECR Minerals #ECR – Technical Director Adam Jones Updates on Bumper Grades in Hole 34
Technical Director Adam Jones discusses the bumper gold grades in hole BH3DD034 at HR3, Bailieston. Adam talks through the gold grades discovered at different levels in zones 1-4, and outlines his conclusions for the collective data picture across the Maori Reef and Hard Up Reef. Alan asks whether there is a case for developing a […]
ECR Minerals #ECR – Multiple High Grade Gold Intercepts from hole BH3DD034 at HR3, Bailieston Victoria
ECR Minerals plc (LON: ECR), the exploration and development company focused on gold in Australia, is pleased to announce a progressive update from drilling at HR3, Bailieston with high gold intercepts received for hole BH3DD034. Visible gold was previously announced from this hole (see announcement dated 14th March 2022) ECR Minerals plc has 100% ownership […]
Open Orphan #ORPH – Final results Reveal Record revenues and EBITDA-profitability accompanied by significant operational progress
Open Orphan (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease products using human challenge clinical trials, announces its audited final results for the 12 months ended 31 December 2021. Financial highlights · Record revenues of £39.0m (2020: £22.2m) achieved representing 76% growth · […]